Melanie Simoes Eugenio
Overview
Explore the profile of Melanie Simoes Eugenio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kara-Ali G, Cano L, Dion S, Imerzoukene G, Hamon A, Simoes Eugenio M, et al.
Int J Cancer
. 2024 Feb;
154(11):1999-2013.
PMID: 38308587
The global pandemic of metabolic diseases has increased the incidence of hepatocellular carcinoma (HCC) in the context of non-alcoholic steatohepatitis (NASH). The downregulation of the E3 ubiquitin ligase TRIM21 has...
2.
Pelletier R, Gicquel T, Simoes Eugenio M, Ferron P, Morel I, Delehouze C, et al.
Pharmaceutics
. 2022 Dec;
14(12).
PMID: 36559159
Sibiriline is a novel drug inhibiting receptor-interacting protein 1 kinase (RIPK1) and necroptosis, a regulated form of cell death involved in several disease models. In this study, we aimed to...
3.
Farooq M, Simoes Eugenio M, Piquet-Pellorce C, Dion S, Raguenes-Nicol C, Santamaria K, et al.
J Mol Med (Berl)
. 2022 Apr;
100(7):1027-1038.
PMID: 35476028
Non-alcoholic steatohepatitis (NASH), a chronic liver disease that emerged in industrialized countries, can further progress into liver fibrosis, cirrhosis, and hepatocellular carcinoma. In the next decade, NASH is predicted to...
4.
Ahmadu A, Delehouze C, Haruna A, Mustapha L, Lawal B, Udobre A, et al.
Molecules
. 2021 Aug;
26(15).
PMID: 34361750
The purpose of this work is to investigate the protein kinase inhibitory activity of constituents from stem bark. Column chromatography and NMR spectroscopy were used to purify and characterize betulin...
5.
Simoes Eugenio M, Faurez F, Kara-Ali G, Lagarrigue M, Uhart P, Bonnet M, et al.
Front Mol Biosci
. 2021 May;
8:645134.
PMID: 33937329
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a well-known apoptosis inducer and a potential anticancer agent. When caspases and inhibitors of apoptosis proteins (IAPs) are inhibited, TRAIL induces necroptosis. Molecular...
6.
Simoes Eugenio M, Farooq M, Dion S, Devisme C, Raguenes-Nicol C, Piquet-Pellorce C, et al.
Cancers (Basel)
. 2020 Jun;
12(6).
PMID: 32521615
The increase of the sedentary lifestyle and high-calorie diet have modified the etiological landscape of hepatocellular carcinoma (HCC), with a recrudescence of non-alcoholic fatty liver disease (NAFLD), especially in Western...
7.
Farooq M, Filliol A, Simoes Eugenio M, Piquet-Pellorce C, Dion S, Raguenes-Nicol C, et al.
Cell Death Dis
. 2019 Jan;
10(1):12.
PMID: 30622241
The protein kinase RIPK1 plays a crucial role at the crossroad of stress-induced signaling pathways that affects cell's decision to live or die. The present study aimed to define the...
8.
Fouquet G, Debuysscher V, Ouled-Haddou H, Simoes Eugenio M, Demey B, Rabbind Singh A, et al.
Oncotarget
. 2016 Apr;
7(22):32493-503.
PMID: 27081035
Multidrug resistance MDR proteins (MRPs) are members of the C family of a group of proteins named ATP binding cassette (ABC) transporters. MRPs can transport drugs including anticancer drugs, nucleoside...
9.
Bouhlal H, Ouled-Haddou H, Debuysscher V, Rabbind Singh A, Ossart C, Reignier A, et al.
Oncotarget
. 2016 Jan;
7(9):9832-43.
PMID: 26799423
Polo-like kinase PLK1 is a cell cycle protein that plays multiple roles in promoting cell cycle progression. Among the many roles, the most prominent role of PLK1 is to regulate...